Literature DB >> 24105015

From multidisciplinary to personalized treatment of colorectal liver metastases: 4 reasons to consider RAS.

Jean-Nicolas Vauthey1, Scott E Kopetz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24105015     DOI: 10.1002/cncr.28348

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  8 in total

1.  Mutation Status of RAS, TP53, and SMAD4 is Superior to Mutation Status of RAS Alone for Predicting Prognosis after Resection of Colorectal Liver Metastases.

Authors:  Yoshikuni Kawaguchi; Scott Kopetz; Timothy E Newhook; Mario De Bellis; Yun Shin Chun; Ching-Wei D Tzeng; Thomas A Aloia; Jean-Nicolas Vauthey
Journal:  Clin Cancer Res       Date:  2019-06-20       Impact factor: 12.531

Review 2.  Dealing with an insufficient future liver remnant: Portal vein embolization and two-stage hepatectomy.

Authors:  Yoshikuni Kawaguchi; Heather A Lillemoe; Jean-Nicolas Vauthey
Journal:  J Surg Oncol       Date:  2019-03-01       Impact factor: 3.454

3.  BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection.

Authors:  M Schirripa; F Bergamo; C Cremolini; M Casagrande; S Lonardi; G Aprile; D Yang; F Marmorino; G Pasquini; E Sensi; C Lupi; G De Maglio; N Borrelli; S Pizzolitto; G Fasola; R Bertorelle; M Rugge; G Fontanini; V Zagonel; F Loupakis; A Falcone
Journal:  Br J Cancer       Date:  2015-05-05       Impact factor: 7.640

4.  KRAS mutation in patients undergoing hepatic resection for colorectal liver metastasis: a biomarker of cancer biology or a byproduct of patient selection?

Authors:  Kjetil Søreide; Oddvar M Sandvik; Jon A Søreide
Journal:  Cancer       Date:  2014-08-25       Impact factor: 6.860

Review 5.  Liver Resection in Patients With Synchronous Colorectal Liver and Lung Metastases.

Authors:  Allison Horner; Kendall Lencioni
Journal:  J Adv Pract Oncol       Date:  2016-11-01

6.  Survival after resection of colorectal liver metastases in octogenarians and sexagenarians compared to their respective age-matched national population.

Authors:  Kristoffer Watten Brudvik; Bård Røsok; Usha Naresh; Sheraz Yaqub; Åsmund Avdem Fretland; Knut Jørgen Labori; Bjørn Edwin; Bjørn Atle Bjørnbeth
Journal:  Hepatobiliary Surg Nutr       Date:  2018-08       Impact factor: 7.293

7.  Alteration of FBXW7 is Associated with Worse Survival in Patients Undergoing Resection of Colorectal Liver Metastases.

Authors:  Yoshikuni Kawaguchi; Timothy E Newhook; Hop S Tran Cao; Ching-Wei D Tzeng; Yun Shin Chun; Thomas A Aloia; Arvind Dasari; Scott Kopetz; Jean-Nicolas Vauthey
Journal:  J Gastrointest Surg       Date:  2020-11-17       Impact factor: 3.452

Review 8.  Surgical Management of Colorectal Liver Metastases: Prognostic Indicators and the Impact of RAS Mutation Status.

Authors:  Steven H Wei; Leigh A Samp
Journal:  J Adv Pract Oncol       Date:  2015-09-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.